Related Experiment Video
Updated: Apr 6, 2026

11:38
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
Published on: July 3, 2014
47.6K
CAUSES OF DEATH IN PATIENTS WITH STAGE 0-II BREAST CANCER
Summary
Early-stage breast cancer patients often die from metastases, particularly to the liver, lungs, and brain. Optimizing imaging surveillance after surgery is crucial for improving survival and quality of life in these patients.
Area of Science:
- Oncology
- Radiology
- Medical Imaging
Background:
- Breast cancer remains a leading cause of mortality worldwide.
- Early-stage breast cancer (Stage 0-II) treatment involves surgery (breast conservation or mastectomy).
- Postoperative surveillance plays a role in detecting recurrence and metastasis.
Purpose of the Study:
- To identify the primary causes of death in Stage 0-II breast cancer patients.
- To evaluate the effectiveness of current imaging surveillance protocols.
- To suggest improvements for enhanced patient outcomes.
Main Methods:
- Retrospective review of 113 inpatient records from 2005-2012 at the Iasi Regional Cancer Institute, Romania.
- Patients were stratified by clinical stage (0, I, II) and surgical procedure (breast conservation vs. radical mastectomy).
- Analysis of all diagnostic imaging studies (ultrasound, radiography, CT) performed postoperatively.
Main Results:
- Common sites of metastasis included bone, liver, lung, and lymph nodes.
- Leading causes of death were metastases to the liver, pleura, lung, and brain.
- Time from recurrence to death was significantly shorter with multiple metastases (0-3 years) compared to single metastases (0-24 years).
Conclusions:
- Metastatic disease is the primary driver of mortality in early-stage breast cancer.
- Current imaging surveillance protocols may require optimization.
- Improved surveillance could enhance prognosis and quality of life for breast cancer survivors.
Related Concept Videos
Cancer Survival Analysis
838
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
838
Electron Transport Chain: Complex I and II
19.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.6K
The Intrinsic Apoptotic Pathway
9.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K
Metastasis
6.9K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.9K
Cancer Therapies
10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K

